Some Thoughts About CBD
It’s painful to see something you love cheapened. Last July at the International Cannabinoid Research Society, I asked Martin Lee and Fred Gardner, co-founders of Project CBD, what they and we, early adopters and proponents of CBD, should do about its out-sized popularity at the moment.
Poor THC, the workhorse of whole plant cannabis, is currently a poor step-sibling of the media and legislative darling CBD. How did ignoring CBD because of ignorance turn into trampling on THC? Or, as I said when the Kentucky and Utah state legislatures looked at legalizing only CBD, or worse yet, legalizing one so-called strain of it: “CBD YES! THC YES!” I could have gone on to say “Charlotte’s Web maybe. ACDC yes. Cannatonic yes. Harley OG yes. R L Pena yes. And my first CBD friend Harlequin yes. (The list could seriously go on and on.)
Everyday we receive multiple requests for CBD from people who have cancer. They experience immense relief that they have found us who have been raising CBD and making cannabis oil as high as 70% in CBD for several years. And then we have to tell them that the confusion on the web, the get quick rich schemes of carpetbaggers coming into what they hope is the fast money of cannabis oil and mistakes repeated as facts so many times that the mistakes develop “legs” and respectability from repetition. I, who raised CBD and made CBD rich oil before anyone I knew, am too often in the position of explaining to cannabis novices that their understanding of cannabis therapeutics is quite flawed. Most of the research has been done on THC, and most of the serious pain and cancer studies find results from THC. Some, like the work of Sean McAllister, point to the increased effectiveness of each (THC and CBD) in anti tumor activity when combined, aka synergy.
I am very pleased to represent CBD as well as we do. We have multiple CBD rich strains, some have registered as high as 40:1, and they routinely test out at 25:1 AND 20:1 CBD:THC. They have different attributes and speak best to slightly different applications and different individuals. We ally ourselves with farmers and breeders who are stabilizing and producing CBD strains from old phenotypes found on their land from decades ago. The forefront of CBD is at the level of the farmer, breeder and patient. The Northern California terroir driven, local obsession with cannabis developed into a model of hands on benefit to individuals from whole plant genetics. That model, rather than a financial driven corporate model that swoops into the next big thing is the model we endorse here at Constance Pure Botanical Extracts.
I would like to address other aspects of this topic in future blog posts: what CBD is uniquely good for; what patients tell us they experience, myths about CBD—isn’t it non psychoactive? Why not take CBD from hemp sources? Isn’t it cheaper? Isn’t it the same? Stay tuned, and thanks for checking in.